Search

Search Constraints

You searched for: Author/Creator Busschaert, Pieter

Search Results

1. 2022-RA-1136-ESGO A single-cell map of rare ovarian cancer. (20th October 2022)

2. 2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer. (20th October 2022)

3. 2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test. (20th October 2022)

10. Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors. Issue 9 (3rd November 2019)